No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
265 |
4. Check minimum number of eventsNone |
265 |
5. Include endpointsNone |
265 |
6. Filter based on genotype QC (FinnGen only) |
252 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Malignant neoplasm of adrenal gland, including Hilmo
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 252 | 131 | 121 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.06 |
| Median age at first event (years) | 57.70 | 54.53 | 61.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 265
- Matched controls
- 2650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
336.6
143.8
134
8
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
80.5
130.6
71
12
130
Kela drug reimbursment
Malignant tumour
+∞
110.3
98
*
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
+∞
107.9
96
*
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
+∞
104.2
93
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
459.0
96.7
91
*
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
91.0
82
*
H02AB09
ATC
hydrocortisone; systemic
25.8
87.1
65
33
H02AB02
ATC
dexamethasone; systemic
45.0
74.0
45
12
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
71.1
65
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
+∞
64.2
59
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.9
55.4
85
134
JN4BD
NOMESCO Finland
Extensive body CT
14.5
53.1
52
44
A04AA01
ATC
ondansetron; systemic, rectal
16.2
49.7
45
33
WX302
NOMESCO Finland
Thoracal epidural anesthesy
18.9
47.0
39
24
JN4AD
NOMESCO Finland
Body CT examination
13.0
43.6
45
41
8700/3-C74.9
ICD-O-3
Pheochromocytoma, NOS, of adrenal gland, NOS
+∞
41.8
39
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.0
36.7
82
185
8370/3-C74.0
ICD-O-3
Adrenal cortical carcinoma of cortex of adrenal gland
+∞
35.2
33
*
L01XX23
ATC
mitotane; oral
+∞
35.2
33
*
XW000
NOMESCO Finland
Bone marrow biopsy
15.0
34.6
32
24
A04AA02
ATC
granisetron; systemic, transdermal
365.7
32.6
32
*
Z51.5
ICD-10 Finland
Palliative care
13.9
32.1
31
25
8700/3-C74.1
ICD-O-3
Pheochromocytoma, NOS, of medulla of adrenal gland
+∞
31.9
30
*
WX402
NOMESCO Finland
General anaesthesia
4.2
23.8
82
256
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
23.3
22
*
H02AA02
ATC
fludrocortisone; oral
42.7
22.2
27
7
ZXE20
NOMESCO Finland
More than three and less than five hours
4.6
21.9
62
166
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
20.9
127
569
JN3AD
NOMESCO Finland
Abdominal CT examination
5.1
20.9
49
112
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.0
19
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.6
20.0
30
44
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
113.6
19.9
21
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
19.5
35
62
N02AA05
ATC
oxycodone; systemic
4.3
19.5
60
170
L03AA02
ATC
filgrastim; parenteral
+∞
19.0
18
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
19.0
18
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
17.7
92
369
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
13.9
17.6
30
24
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
17.2
143
747
9500/3-C74.1
ICD-O-3
Neuroblastoma, NOS, of medulla of adrenal gland
+∞
16.8
16
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
16.4
46
121
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
16.3
66
225
Z31.5
ICD-10 Finland
Genetic counselling
6.0
16.1
30
55
ZX120
NOMESCO Finland
Intravenous
5.1
15.4
35
77
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
15.0
73
278
WZC00
NOMESCO Finland
Treatment plan or consultation
2.9
15.0
104
484
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
84.9
14.7
16
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.7
14
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
14.7
14
*
BC5AQ
NOMESCO Finland
Chromaffine tissue SPECT with low dose CT
+∞
14.7
14
*
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
45.1
14.3
17
*
B01AB05
ATC
enoxaparin; parenteral
2.9
14.2
93
418
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
18.9
14.1
21
12
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
79.3
13.7
15
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
22.6
13.5
19
9
WZC30
NOMESCO Finland
Teaching
3.5
13.4
52
171
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
12.8
52
176
L01BC06
ATC
capecitabine; oral
+∞
12.6
12
*
B01AB10
ATC
tinzaparin; parenteral
4.3
12.0
33
85
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
11.9
11.8
21
19
L03AA13
ATC
pegfilgrastim; parenteral
68.0
11.7
13
*
BC5AN
NOMESCO Finland
Chromaffine and adrenergic tissue isotope imaging (MIBG)
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
11.5
11
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.0
11.5
18
12
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.8
11.1
18
13
WW500
NOMESCO Finland
Blood transfusion
8.9
11.1
23
28
JN4CD
NOMESCO Finland
Very extensive body CT
16.4
11.0
17
11
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.3
11.0
20
19
J01MA12
ATC
levofloxacin; systemic
3.0
11.0
58
229
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
62.6
10.7
12
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
114.4
10.5
11
*
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
114.4
10.5
11
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
114.4
10.5
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.5
10
*
D35.59
ICD-10 Finland
Other paragangliom
+∞
10.5
10
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
34.0
10.4
13
*
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
41.8
10.0
12
*
BC1AD
NOMESCO Finland
CT of adrenal glands
17.6
10.0
15
9
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.9
10.0
31
87
H03AA01
ATC
levothyroxine sodium; systemic
2.5
9.8
75
356
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
9.8
111
630
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.5
9.5
19
37
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.8
9.5
22
49
2533
FHL
Unilateral removal of additional egg
103.6
9.5
10
*
E24.8
ICD-10 Finland
Other Cushing syndrome
103.6
9.5
10
*
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
103.6
9.5
10
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.2
9.5
20
41
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
9.4
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.4
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.4
9
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.7
9.3
22
50
ZXE00
NOMESCO Finland
One hour or less
2.2
9.2
114
667
N05BA06
ATC
lorazepam; systemic, sublingual
4.5
9.1
23
55
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
9.1
32
98
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.8
9.0
21
47
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
8.7
33
106
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.3
8.5
18
23
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.3
8.4
15
14
BC1BD
NOMESCO Finland
Extensive CT of adrenal glands
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
1940B
ICD-9 Finland
Malignant neoplasm of other endocrine glands and related structures, Adrenal gland[NEUROBLASTOMA SUPRARENALIS]
+∞
8.4
8
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
8.4
8
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
8.4
8
*
9101
FHL
Bone biopsy
+∞
8.4
8
*
WF002
NOMESCO Finland
Radical radiotherapy
34.5
8.1
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
8.1
31
100
N02AA01
ATC
morphine; systemic, rectal
22.9
8.1
11
5
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
46.4
7.8
9
*
JAH00
NOMESCO Finland
Laparotomy
7.5
7.6
17
24
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
7.5
26
79
ZX121
NOMESCO Finland
Central venous catheter
82.3
7.5
8
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
7.4
82
452
N02AX02
ATC
tramadol; systemic, rectal
2.0
7.4
117
738
C74
ICD-10 Finland
Malignant neoplasm of adrenal gland
+∞
7.3
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
Y77
ICPC
Malignant neoplasm prostate
+∞
7.3
7
*
9109
FHL
Other measure in this category
+∞
7.3
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
7.3
7
*
116
Kela drug reimbursment
Prostate cancer
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
7.3
7
*
8010/3-C74.9
ICD-O-3
Carcinoma, NOS, of adrenal gland, NOS
+∞
7.3
7
*
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
9.7
6.9
13
14
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
41.1
6.8
8
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
41.1
6.8
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
6.8
62
315
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
6.7
27
90
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.4
6.7
17
41
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
71.5
6.5
7
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
71.5
6.5
7
*
Z2446
NOMESCO Finland
Social worker
2.9
6.4
31
115
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
6.4
18
47
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
18.6
6.3
9
5
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
6.3
6
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
6.3
6
*
V04CD01
ATC
metyrapone; oral
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
8370/3-C74.9
ICD-O-3
Adrenal cortical carcinoma of adrenal gland, NOS
+∞
6.3
6
*
R50.9
ICD-10 Finland
Fever, unspecified
2.3
6.2
50
240
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
6.2
16
39
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.9
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
100
33
48.06
159.68
4.2
1.2
—
—
nmol/l
—
0
0
37
9
47.40
30.85
7.4
1.3
24.31
13.37
ug/l
—
37
9
27
8
37.35
21.58
1.3
1.4
307.35
59.38
nmol/24h
—
27
8
175
940
3.54
21.50
11.8
3.8
13.92
13.86
umol/l
0.01
170
877
77
248
3.97
21.15
7.6
7.8
1.12
1.12
mmol/l
0.02
72
230
42
87
5.55
19.96
3.3
1.5
4.39
2.29
ug/l
0.72
35
68
168
929
3.21
18.70
14.2
7.0
1.21
1.22
mmol/l
0.74
135
808
153
824
3.03
17.45
3.8
2.3
—
—
—
0
0
52
152
4.01
16.06
2.4
2.5
0.22
0.20
g/l
0.49
47
140
48
133
4.19
15.94
6.3
3.2
1.22
1.23
mmol/l
0.11
48
114
56
179
3.70
15.18
6.3
8.3
13.82
11.80
kpa
1.47
51
171
56
179
3.70
15.18
6.3
8.3
5.26
5.23
kpa
0.06
51
170
184
1157
2.93
14.77
10.2
4.7
6.49
6.71
mmol/l
0.66
177
1060
54
179
3.53
13.79
6.4
8.3
0.62
1.57
mmol/l
0.89
45
144
108
548
2.64
12.81
4.6
3.2
0.31
0.32
e6/l
0.04
90
399
69
284
2.93
12.19
2.9
2.2
29.86
29.59
s
0.17
69
275
49
167
3.37
11.90
4.7
2.9
—
—
—
0
0
87
411
2.66
11.77
3.8
2.0
—
—
—
0
0
38
110
3.87
11.77
1.5
1.4
—
—
—
0
0
121
682
2.42
11.13
4.5
3.3
—
—
—
0
0
107
571
2.47
11.11
6.9
2.0
2.35
2.35
mmol/l
0.14
101
477
21
39
5.76
11.06
2.6
2.0
28.06
16.97
u/ml
0.38
16
32
139
838
2.39
10.92
15.3
14.1
1.16
1.33
inr
1.87
58
252
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
41
5.48
10.50
2.1
4.6
0.36
0.35
u/ml
0.05
15
26
61
257
2.78
10.18
2.1
2.6
24.63
22.68
%
0.27
53
229
53
209
2.92
9.98
7.4
3.4
11.87
7.25
umol/l
0.27
47
177
168
1131
2.33
9.82
22.7
6.6
4.05
4.16
e9/l
0.24
155
977
20
40
5.33
9.73
1.8
1.5
—
—
—
0
0
51
202
2.89
9.51
1.8
1.7
—
—
—
0
0
64
286
2.63
9.47
2.1
1.7
—
—
—
0
0
20
42
5.07
9.22
1.7
1.5
—
—
—
0
0
17
18
10.01
8.91
1.8
1.4
—
—
—
0
0
49
203
2.73
8.35
1.9
1.8
—
—
—
0
0
42
162
2.89
8.17
20.5
12.6
24.72
24.82
mmol/l
0.06
42
162
19
43
4.68
8.03
1.3
1.4
—
—
—
0
0
106
633
2.12
7.86
4.8
3.0
31.07
30.58
u/l
0.08
100
596
17
24
7.49
7.61
2.6
3.8
16.52
50.22
mu/l
0.54
17
24
12
9
13.89
7.46
5.2
4.3
—
—
—
0
0
10
5
20.69
7.18
1.9
1.0
40.23
1.95
umol/24h
—
10
5
23
66
3.72
7.17
3.5
2.2
14.03
8.81
u/l
0.65
17
52
18
43
4.42
7.13
1.1
1.3
—
—
—
0
0
21
57
3.92
7.06
4.0
3.9
99.76
88.70
%
1.21
21
57
16
25
6.74
6.75
1.8
1.2
—
—
—
0
0
25
82
3.26
6.38
2.8
2.0
20.30
16.94
iu/l
0.20
20
66
14
20
7.32
6.30
1.4
1.2
—
—
—
0
0
84
502
1.99
5.93
2.2
2.2
3.02
2.91
mg/l
0.16
73
431
17
45
3.97
5.91
1.5
3.4
—
—
—
0
0
16
31
5.42
5.80
1.5
1.2
—
—
—
0
0
16
31
5.42
5.80
1.8
1.3
—
—
—
0
0
174
1338
1.87
5.47
4.2
3.1
73.49
44.44
u/l
1.86
162
1245
5
0
+∞
5.22
3.2
0.0
20.68
—
u/ml
—
5
0
15
31
5.06
5.20
2.7
3.3
15.16
17.02
%
—
9
16
59
324
2.06
5.20
4.3
3.1
2.69
2.31
e6/l
0.13
33
175
9
9
10.30
5.06
1.8
1.1
—
—
—
0
0
26
101
2.75
4.97
1.6
1.6
—
—
—
0
0
37
172
2.34
4.91
6.5
8.8
1.95
1.41
mmol/l
0.37
32
124
15
34
4.61
4.83
3.4
3.9
4.94
4.80
kpa
0.24
15
34
36
168
2.32
4.73
2.4
2.0
24.79
37.65
u/l
1.28
29
139
61
351
1.96
4.69
4.0
2.8
0.31
0.96
e6/l
3.88
34
201
7
5
14.32
4.60
2.0
1.0
—
—
—
0
0
194
1587
1.83
4.53
5.9
3.8
14.67
14.81
pmol/l
0.31
181
1431
15
37
4.23
4.48
3.0
1.4
—
—
—
0
0
12
24
5.18
4.37
1.5
1.7
—
—
—
0
0
12
24
5.18
4.37
1.5
1.7
—
—
—
0
0
10
16
6.45
4.33
1.5
1.3
—
—
—
0
0
11
22
5.17
4.05
1.1
1.1
—
—
—
0
0
61
368
1.85
4.03
4.4
3.7
704.66
224.19
ng/l
0.46
47
272
10
18
5.73
4.01
1.9
1.2
—
—
—
0
0
163
1295
1.67
3.95
5.3
4.1
7.80
381.37
e6/l
—
5
16
185
1527
1.70
3.80
4.6
4.1
15.82
11.16
mm/h
2.97
175
1386
6
5
12.23
3.78
2.2
1.0
—
—
—
0
0
6
5
12.23
3.78
1.3
3.6
—
—
—
0
0
109
790
1.65
3.73
3.1
2.5
75.77
75.58
nmol/l
0.02
104
695
12
30
4.14
3.64
1.9
8.1
—
267.40
—
0
5
7
9
7.95
3.58
2.6
1.3
5.43
3.98
nmol/l
—
7
9
8
13
6.31
3.52
4.4
1.9
962.88
563.62
e6/l
—
8
13
7
10
7.15
3.38
2.1
5.3
1.88
1.84
ug/l
—
7
10
12
33
3.76
3.33
1.6
1.6
—
—
—
0
0
12
33
3.76
3.33
1.6
1.6
—
—
—
0
0
11
28
4.05
3.33
1.8
1.4
—
—
—
0
0
6
7
8.73
3.28
2.3
1.9
—
—
—
0
0
6
7
8.73
3.28
2.2
1.0
—
—
—
0
0
118
894
1.58
3.25
3.3
2.8
196.59
93.28
ug/l
2.57
113
826
8
15
5.46
3.21
2.0
1.1
—
—
—
0
0
13
41
3.28
3.10
2.0
1.6
—
—
—
0
0
13
45
2.99
3.07
1.5
2.1
—
—
—
0
0
68
462
1.63
2.90
1.6
1.5
18.50
20.87
nmol/l
0.67
63
391
11
33
3.43
2.84
2.7
3.5
53.91
55.67
%
0.12
11
33
79
565
1.57
2.71
3.0
3.3
2942.06
1292.01
ng/l
0.81
64
465
6
10
6.11
2.71
2.0
1.6
—
—
—
0
0
8
20
4.09
2.59
1.9
1.3
—
—
—
0
0
13
50
2.68
2.57
1.5
1.8
—
—
—
0
0
13
50
2.68
2.57
1.5
1.9
176.25
249.70
u/ml
—
8
20
7
16
4.46
2.49
1.6
1.0
—
—
—
0
0
10
33
3.11
2.38
1.2
1.2
—
—
—
0
0
10
33
3.11
2.38
1.2
1.2
—
—
—
0
0
10
33
3.11
2.38
2.8
3.0
2.69
4.19
e9/l
—
10
33
8
22
3.72
2.38
1.9
1.3
—
—
—
0
0
37
226
1.74
2.33
21.4
5.4
2.13
1.85
mmol/l
0.26
32
179
8
24
3.40
2.20
1.1
1.4
—
—
—
0
0
6
14
4.36
2.16
1.5
1.3
—
—
—
0
0
11
44
2.56
2.04
2.3
1.2
—
1.11
—
0
6
56
398
1.52
1.94
1.9
1.7
445.07
440.03
pmol/l
0.05
46
320
213
1935
1.51
1.93
6.0
4.5
1.81
1.95
mu/l
0.88
198
1751
6
17
3.59
1.85
1.0
1.0
—
—
—
0
0
5
12
4.22
1.83
1.2
1.9
—
—
—
0
0
7
24
2.97
1.73
1.0
1.5
—
—
—
0
0
6
145
0.40
1.70
1.0
1.1
—
—
—
0
0
119
993
1.36
1.68
3.8
3.7
0.00
0.02
estimate
0.50
37
166
117
976
1.36
1.65
5.7
5.2
0.00
0.00
estimate
-0.00
38
167
203
1850
1.42
1.60
26.9
9.7
82.34
81.87
ml/min/173m2
0.10
180
1466
117
980
1.35
1.59
3.8
3.7
0.00
0.01
estimate
0.50
40
184
14
254
0.53
1.56
10.6
6.8
—
—
—
0
0
8
33
2.47
1.55
1.1
1.3
—
—
—
0
0
203
1854
1.41
1.55
39.0
13.2
14.54
14.68
%
0.18
198
1826
66
506
1.41
1.54
3.6
3.8
0.00
0.00
estimate
-0.00
33
167
5
16
3.16
1.44
2.6
1.7
—
—
—
0
0
5
16
3.16
1.44
1.0
1.0
—
—
—
0
0
66
516
1.37
1.37
3.3
2.5
332.71
8211.52
umol/l
2.49
59
449
55
417
1.40
1.37
2.5
1.8
1.33
0.92
mg/l
0.99
40
314
213
1976
1.40
1.35
4.5
4.3
5.92
5.92
mmol/l
0.00
204
1791
9
43
2.13
1.31
1.3
1.8
—
—
—
0
0
11
55
2.04
1.29
1.5
1.6
1.01
0.69
nmol/l
0.91
11
46
89
736
1.32
1.27
4.6
3.5
30.74
40.80
ng/l
0.69
63
503
23
148
1.61
1.25
3.4
2.3
59.90
66.91
ml/min/173m2
—
10
53
94
786
1.30
1.24
1.8
1.9
82.40
95.85
pmol/l
2.06
44
385
5
106
0.46
1.03
2.2
1.5
—
—
—
0
0
16
99
1.66
1.02
1.6
1.5
—
—
—
0
0
202
1887
1.30
1.01
6.2
5.7
40.00
39.88
mmol/mol
0.07
195
1748
11
61
1.84
1.00
2.0
1.5
—
—
—
0
0
34
443
0.73
0.91
1.5
1.7
—
—
—
0
0
8
43
1.89
0.88
2.0
2.9
9.53
6.36
umol/l
—
8
34
21
146
1.48
0.85
1.3
1.2
62.90
94.21
iu/ml
—
10
59
11
65
1.72
0.83
1.9
1.6
—
—
—
0
0
86
745
1.23
0.81
3.9
3.7
—
—
—
0
0
74
631
1.24
0.80
3.9
3.8
23.82
38.27
mg/mmol
0.20
47
391
128
1406
0.83
0.80
3.1
3.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
219
2096
1.26
0.70
27.1
11.1
31.06
21.81
mg/l
3.17
199
1564
18
248
0.71
0.69
3.6
4.8
32.69
31.26
%
0.19
13
159
5
29
1.74
0.64
1.2
1.6
—
—
—
0
0
44
526
0.80
0.63
1.3
1.5
0.84
2.16
u/ml
1.57
13
136
5
30
1.68
0.61
1.6
2.2
105.00
105.50
mmol/l
—
5
30
0
20
0.00
0.60
0.0
1.0
—
18.91
—
0
20
8
55
1.47
0.56
1.0
1.2
—
—
—
0
0
8
121
0.65
0.56
1.0
1.3
—
—
—
0
0
6
37
1.64
0.56
1.2
1.2
—
—
—
0
0
12
169
0.70
0.54
1.8
1.7
—
—
—
0
0
9
65
1.40
0.51
2.2
1.1
9.44
11.58
g/l
—
9
58
62
546
1.18
0.49
2.5
1.6
2.01
1.37
mmol/l
0.95
56
466
13
93
1.42
0.49
31.5
3.5
0.68
0.61
%
0.24
13
93
208
2005
1.17
0.47
4.6
4.4
4.80
4.64
mmol/l
1.16
192
1862
211
2039
1.17
0.44
5.0
4.9
2.82
2.76
mmol/l
0.36
193
1884
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
5
34
1.48
0.40
1.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
1.2
1.1
—
—
—
0
0
228
2224
1.18
0.38
19.4
8.4
27.09
26.14
u/l
0.28
221
2120
9
71
1.28
0.36
2.2
1.2
3.46
3.78
g/l
—
9
64
9
71
1.28
0.36
2.2
1.2
—
—
—
0
0
9
71
1.28
0.36
2.2
1.2
8.30
7.50
g/l
—
9
64
16
126
1.29
0.36
2.2
1.8
—
—
—
0
0
38
433
0.86
0.35
4.2
3.7
1.02
1.02
kg/l
0.07
11
64
6
45
1.34
0.34
1.3
1.4
—
—
—
0
0
198
1922
1.12
0.31
4.5
3.9
1.52
1.26
mmol/l
3.38
182
1763
34
386
0.86
0.30
1.4
1.3
46.36
40.77
iu/ml
0.08
15
126
234
2378
0.86
0.27
43.7
16.7
38.47
40.33
%
4.87
222
2203
234
2378
0.86
0.27
41.9
16.6
4.34
4.54
e12/l
6.99
228
2287
8
65
1.24
0.27
1.3
1.5
—
0.19
—
0
15
204
1990
1.11
0.26
4.6
4.4
1.44
1.47
mmol/l
0.47
187
1837
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
31
350
0.87
0.26
1.3
1.3
5.19
14.06
u/ml
—
7
139
5
74
0.67
0.26
1.0
1.2
—
—
—
0
0
234
2376
0.87
0.25
42.2
16.6
267.75
251.48
e9/l
2.31
228
2290
6
81
0.73
0.24
1.0
1.7
2.25
2.39
mg/l
—
6
55
5
40
1.25
0.22
1.0
1.3
60.60
52.80
pmol/l
—
5
40
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
39
356
1.11
0.20
2.0
1.7
1319.60
1231.26
nmol/l
0.20
28
273
12
99
1.22
0.20
2.0
1.7
—
—
—
0
0
6
51
1.18
0.19
1.0
1.3
—
47.55
—
0
6
7
60
1.17
0.18
1.7
1.3
—
—
—
0
0
10
83
1.21
0.15
1.5
1.7
—
117.14
—
0
7
9
79
1.14
0.15
1.8
1.5
—
—
—
0
0
47
500
0.93
0.15
3.6
3.4
20.89
24.38
%
0.41
25
221
37
347
1.08
0.12
2.9
2.5
0.94
0.74
ug/l
0.37
24
216
6
58
1.04
0.08
1.2
1.2
32.17
38.98
g/l
—
6
51
7
68
1.03
0.08
1.7
1.1
—
—
—
0
0
8
78
1.03
0.07
1.4
2.2
—
—
—
0
0
24
226
1.07
0.07
1.9
2.0
—
—
—
0
0
29
300
0.96
0.03
1.4
1.3
—
—
—
0
0
63
620
1.02
0.02
4.4
3.6
3.12
1.91
ug/l
0.58
52
551
25
254
0.98
0.00
2.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
56
0.89
-0.00
1.8
1.6
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
-0.00
0.0
1.0
—
131.60
—
0
5
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
-0.00
0.0
2.8
—
115.33
—
0
6
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
-0.00
1.1
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
1.2
1.2
3.28
2.91
g/l
—
6
59
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_ADRENAL_GLAND_WIDE – Malignant neoplasm of adrenal gland, including Hilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).